-
Signature
-
/s/ Timothy C. Dec, as attorney-in-fact
-
Issuer symbol
-
SUPN
-
Transactions as of
-
01 Oct 2025
-
Transactions value $
-
-$570,356
-
Form type
-
4
-
Filing time
-
02 Oct 2025, 16:02:42 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Khattar Jack A. |
President, CEO, Director |
C/O SUPERNUS PHARMACEUTICALS INC., 9715 KEY WEST AVENUE, ROCKVILLE |
/s/ Timothy C. Dec, as attorney-in-fact |
02 Oct 2025 |
0001539937 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SUPN |
Common Stock |
Options Exercise |
$1,360,760 |
+53,785 |
+4.69% |
$25.30 |
1,201,043 |
01 Oct 2025 |
Direct |
F1 |
| transaction |
SUPN |
Common Stock |
Sale |
-$1,931,116 |
-40,173 |
-3.34% |
$48.07 |
1,160,870 |
01 Oct 2025 |
Direct |
F2 |
| holding |
SUPN |
Common Stock |
|
|
|
|
|
1,005,600 |
01 Oct 2025 |
By the KBT Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SUPN |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-53,785 |
-39.2% |
$0.000000 |
83,517 |
01 Oct 2025 |
Common Stock |
53,785 |
$25.30 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: